 |
[ login or create an account ]
|
|
[ login or create an account ]
|
News (1079)
Politics (359)
Business (61)
National (111)
Sport (1)
Health (546)
Technology (1)
Fuseworks Media (1073)
Voxy Newswire (6)
I'm looking for ...
Displaying 1 - 10 of 1079 results
Subscribe to an RSS feed of this search 
Pharmac has announced today that it will be funding the preventative treatment, palivizumab, for the next two seasons of respiratory syncytial virus (RSV) for young children with severe diseases who need to be ventilated and pÄpi (babies) with a high susceptibility for RSV-related illness and
The final report of the Independent Pharmac Review Panel has been sitting with Health Minister Andrew Little since February, with no reason offered for why it has not been released, says Myeloma NZ Chief Executive Dr Ken Romeril.
Today’s cancer medicines analysis from Cancer Control Agency Te Aho o Te Kahu shows how far New Zealand has fallen behind in the past five years, National’s Health spokesperson Dr Shane Reti says.
The report released today by Te Aho o Te Kahu (the Cancer Control Agency) Understanding the Gap: an analysis of the availability of cancer medicines in Aotearoa is a small step in the right direction, but there is still a long way to go.
Responding to the Cancer Control Agency’s latest report on the funding of cancer drugs in Aotearoa (embargoed to 28 April), Ah-Leen Rayner, chief executive of Breast Cancer Foundation NZ, said:
Te Aho o Te Kahu, the Cancer Control Agency, has today released Understanding the Gap: an analysis of the availability of cancer medicines in Aotearoa.
Pharmac welcomes a new report released today by Te Aho o Te Kahu (the Cancer Control Agency) which analyses the access and efficacy of cancer medicines for solid tumours in adult patients in Aotearoa.
Pharmac has released the Pacific peoples health - Gout data insights report today. The report shows that, while the prevalence of gout in Pacific peoples continues to climb, access to preventive gout medicine remains inequitable.
On Monday 28 March, Carmen Shanks presented her Parliamentary Petition to MP Shanan Halbert, urging the Government to fund Trikafta, the first medicine that can treat the cause of cystic fibrosis for the majority of those who have the condition.
The first shipment of Pfizer’s new oral antiviral treatment for COVID-19, Paxlovid, has arrived in New Zealand and will be available for those who need it from next week.
Voxy: Your Voice